FDA Keeps Tabs on Faulty Gadgets: Device Reports Roll On
Published Date: 7/29/2025
Notice
Summary
The FDA wants to keep track of reports about problems with medical devices to keep everyone safe. They’ve sent a plan to the government to keep collecting this info, and they’re asking for your thoughts before moving forward. This affects medical device makers and could mean some paperwork, but it helps catch device issues faster!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Keeps tracking device problems to improve safety
The FDA will continue collecting reports about problems with medical devices so issues can be found and addressed faster. You may be safer because this reporting helps the FDA detect device problems and protect people from unsafe devices.
Continued medical device reporting paperwork
If you make medical devices, the FDA has submitted a plan to keep collecting reports about device problems. This could mean continued or additional paperwork for device makers to submit reports and related information to the FDA.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2025-14229, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export Notification and Recordkeeping Requirements
The FDA is asking the Office of Management and Budget to review new rules about how companies report and keep records when they export certain products. This affects businesses that send goods out of the country and might change how they track and share information. No big costs or deadlines yet, but stay tuned for updates once the review is done!
Next: 2025-14231, Agency Information Collection Activities: Office for Bombing Prevention-Technical Analytics
The Office for Bombing Prevention at CISA is asking for approval to keep collecting important info to help stop bomb threats. They already asked for feedback earlier this year but got zero comments, so now they’re giving the public 30 more days to speak up. This won’t cost anyone extra but helps keep everyone safer by improving how info is gathered and used.